Bausch Health Companies (BHC) Capital Expenditures (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Capital Expenditures data on file, last reported at $109.0 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 5.22% year-over-year to $109.0 million; the trailing twelve-month figure through Mar 2026 stood at $391.0 million (up 5.68% YoY), and the FY2025 full-year result was $397.0 million, up 17.8% from the prior year.
• Capital Expenditures climbed to $109.0 million in Q1 2026, from $92.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $115.0 million in Q1 2025 to a low of $28.0 million in Q2 2023.
• A 5-year average of $75.1 million and a median of $78.0 million in 2024 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures plunged 46.15% in 2023 and surged 178.57% in 2024, its largest moves.
• Tracing BHC's Capital Expenditures over 5 years: stood at $66.0 million in 2022, then soared by 48.48% to $98.0 million in 2023, then increased by 8.16% to $106.0 million in 2024, then retreated by 13.21% to $92.0 million in 2025, then gained by 18.48% to $109.0 million in 2026.
• Business Quant data shows BHC's Capital Expenditures at $109.0 million in Q1 2026, $92.0 million in Q4 2025, and $91.0 million in Q3 2025.